Although BNP has been associated with long-term LVDD progression in patients with T2D [15], and BNP is recognized as a gold-standard biomarker for cardiac function and is recommended in current heart failure guidelines [16], it has several well-documented limitations. This evidence concerns the gene NPPB and type 2 diabetes mellitus.